Author:
Molea N.,Bodei L.,Lazzeri E.,Bacciardi D.,Giulianotti P. C.,Balestracci D.,Viacava P.,Campani D.,Di Luca L.,Salvadori P. A.,Bonino C.,Gold D. V.,Sharkey R. M.,Goldenberg D. M.,Mosca F.,Mariani G.
Reference4 articles.
1. Prat M, Morra I, Bussolati G, Comoglio PM. CAR-3, a monoclonal antibody-defined antigen expressed on human adenocarcinomas. Cancer Res 1985; 45: 5799–807.
2. Prat M, Medico E, Rossino P, Garrino C, Comoglio PM. Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3. Cancer Res 1989; 49: 1415–21.
3. Brusa P, Pietribiasi F, Bussolati G et al. Blocked and not blocked whole-ricin antibody immunotoxins: intraperitoneal therapy of human cancer xenografted in nude mice. Cancer Immunol Immunother 1989; 29: 185–92.
4. Gold DV, Lew K, Maliniak R, Hernandez M, Cardillo T. Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin. !nt J Cancer 1994; 57: 204–10.